There are 3161 resources available
1759P - Long-term updated outcomes of a phase II study of ripretinib vs. sunitinib in chinese patients with advanced gastrointestinal stromal tumor
Presenter: Jian Li
Session: Poster session 06
1760P - Impact of adjuvant imatinib on recurrence for neurofibromatosis type 1 (NF1) associated GISTs: An analysis of the RECKGIST cohort from the French NETSARC+ network
Presenter: Vincent Hautefeuille
Session: Poster session 06
1761P - Clinical description and development of a prognosis score for neurofibromatosis type 1 (NF1) associated GISTs in the RECKGIST cohort: A retrospective study from the French NETSARC+ network
Presenter: Charlotte Cuvelier
Session: Poster session 06
1763P - Initial tumour size and residual mitotic count post-neoadjuvant imatinib linked to shorter relapse-free survival in GIST patients
Presenter: Javier Pozas Perez
Session: Poster session 06
1764P - Role of PIK3CA as a predictive biomarker in metastatic, imatinib-resistant GIST: A ct-DNA substudy of the VOYAGER trial
Presenter: Lennart Schardt
Session: Poster session 06
1765P - Second-line targeted therapy patterns and outcomes of advanced gastrointestinal stromal tumor: A prospective, multicentered real-world study
Presenter: Xinhua Zhang
Session: Poster session 06
1766P - Updated results of the RINGSIDE phase II trial and open-label extension of AL102 for treatment of desmoid tumors
Presenter: Bernd Kasper
Session: Poster session 06
1767P - Pegylated liposomal doxorubicin in symptomatic desmoid tumor
Presenter: Kjetil Boye
Session: Poster session 06
1768P - Desmoid tumors: Experience of a Spanish reference center
Presenter: Ana Gutierrez Ortiz
Session: Poster session 06